Dr Reddys Laboratories Stock Sees Decline of -3.43% Amidst Volatile Market Conditions

Dr Reddys Laboratories, a leading pharmaceutical company in the largecap industry, has seen a decline in its stock price by -3.43% on November 18, 2024. This comes after a series of losses in the past four days, with a total decrease of -6.74% during this period. The stock opened today with a loss of -2.75% and reached an intraday low of Rs 1195.6.

According to MarketsMOJO, a leading stock market analysis platform, the current stock call for Dr Reddys Laboratories is 'Hold'. The stock has underperformed the sector by -2.48% today and has been highly volatile with an intraday volatility of 449.26%. This is calculated from the weighted average price.

In terms of moving averages, Dr Reddy's Labs is currently trading lower than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. This indicates a downward trend in the stock's performance.

In comparison to the overall market performance, Dr Reddys Laboratories has seen a decline of -3.53% in the past day, while the Sensex has only decreased by -0.23%. In the past month, the stock has seen a decrease of -12.23%, while the Sensex has decreased by -4.70%.

Overall, the current performance of Dr Reddys Laboratories may not be favorable for investors, but it is important to note that this is a short-term trend and does not reflect the company's long-term potential. Investors are advised to do their own research and consult with a financial advisor before making any investment decisions.